[
  {
    "ts": null,
    "headline": "John Hancock Disciplined Value Mid Cap Fund Q1 2025 Commentary",
    "summary": "John Hancock Disciplined Value Mid Cap Fund outperformed the benchmark. The Russell MidCap Value Indexâthe fundâs benchmarkâreturned â2.11% in the first quarter.",
    "url": "https://finnhub.io/api/news?id=3380e6919cf407e4247a9fc3258823ee50239872e4889419e00c6dc2c39e06f4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748355600,
      "headline": "John Hancock Disciplined Value Mid Cap Fund Q1 2025 Commentary",
      "id": 134710762,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1854677474/image_1854677474.jpg?io=getty-c-w1536",
      "related": "MCK",
      "source": "SeekingAlpha",
      "summary": "John Hancock Disciplined Value Mid Cap Fund outperformed the benchmark. The Russell MidCap Value Indexâthe fundâs benchmarkâreturned â2.11% in the first quarter.",
      "url": "https://finnhub.io/api/news?id=3380e6919cf407e4247a9fc3258823ee50239872e4889419e00c6dc2c39e06f4"
    }
  },
  {
    "ts": null,
    "headline": "John Hancock Disciplined Value Fund Q1 2025 Commentary",
    "summary": "The Russell 1000 Value Indexâthe fundâs benchmarkârecorded a gain of 2.14% in the first quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=c42fd7704f46c785476f7b80ae46a7782023230483292439ca1d9cd559204576",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748348520,
      "headline": "John Hancock Disciplined Value Fund Q1 2025 Commentary",
      "id": 134709697,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1085514446/image_1085514446.jpg?io=getty-c-w1536",
      "related": "MCK",
      "source": "SeekingAlpha",
      "summary": "The Russell 1000 Value Indexâthe fundâs benchmarkârecorded a gain of 2.14% in the first quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=c42fd7704f46c785476f7b80ae46a7782023230483292439ca1d9cd559204576"
    }
  },
  {
    "ts": null,
    "headline": "MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?",
    "summary": "Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.",
    "url": "https://finnhub.io/api/news?id=f137ecb145696377b4ccfdb5734d066a5e3befbfc810a2ed7e47aba0780406e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748348160,
      "headline": "MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?",
      "id": 134716479,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.",
      "url": "https://finnhub.io/api/news?id=f137ecb145696377b4ccfdb5734d066a5e3befbfc810a2ed7e47aba0780406e2"
    }
  }
]